GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Exclusion Criteria

• •Participation in any other clinical trial within the past 3 months or ongoing
• •Occurrence of inconsistency with initial diagnosis at baseline during surgery of the patient leading to unfulfilled inclusion criterion Hemorrhage secondary to tumour or trauma
• •Patients with a cerebellar hemorrhage or extension of a supratentorial hemorrhage into the brainstem
• •Patients with severe pre-existing physical or mental disability or severe comorbidity that interferes with the assessment of outcome
• •Allergy to contrast media (MRT)
• •Acute infection
• •Muscular, neurological, or vascular insufficiency of the respective tissue
• •Polypropylene incompatibility
• •Acute immunosuppressive medication
• •Patient after organ transplantation
• •Patient with immune depression
• •Patients with a high probability of spontaneous recovery or showing rapidly improving signs
• •Patients with extensive intracranial hemorrhages or with deep hemispheric localisation of the clots
• •Patients whose diagnosis of ICH is uncertain